Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers general pharmaceuticals; orphan drugs; antidotes; rapid test kits and reagent; consumer products under the Repavar, Om3gafort, Oral7, and Excelsior Probiotics brand names; and over the counter drugs under the Norit, Puresenna, and Tazac brand names. The company also provides specialty medicine and public health products. In addition, it is involved in importing and exporting of active pharmaceutical …
Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
1,124,627,712
Fair value reference
28.37
Next-week expectancy
Undecided · 50.61%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-14, 6496 rose 5.91%, moving from 22.85 to 24.20. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -37.73 and has improved across the 12-week window. Market Dynamics is 0.37 on the latest week. Next-week expectancy is undecided at 50.61% based on similar historical setup states.
Week Ending
14 Aug 2026
Latest Close
24.20
12-Week Change
5.91%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 50.61%
Signal Weeks
0 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Resistance
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateBelow accepted value
52-week position
21.1%
Low to high
Accepted price
29.25
Latest versus accepted: -17.25%
Fitted direction
Falling
-0.51% per week
Range pressure
40/100
Balanced pressure
Range condition
Normal
0.93× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support22.50
From price
-7.0%
Evidence
26/100
Touches
1
Support23.50
From price
-2.9%
Evidence
49/100
Touches
3
Current pivot24.17
From price
-0.1%
Evidence
55/100
Touches
2
Resistance24.66
From price
1.9%
Evidence
45/100
Touches
1
Resistance28.50
From price
17.8%
Evidence
82/100
Touches
5
Resistance29.25
From price
20.9%
Evidence
96/100
Touches
4
Current reading
What the range shows
Current positionBelow accepted value
Price is at 21.1% of its latest 52-week range.
Fitted directionFalling
The fitted centre line is moving -0.51% per week.
Range pressureBalanced pressure
The current pressure reading is 40/100; 50 is balanced.
Next structural level23.50
Support is 2.9% from the latest close with 49/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
14 Aug 2026
Latest Close
24.20
12-Week Change
5.91%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 50.61%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-37.73
Market Dynamics
0.37
Over the latest 12 completed weeks ending 2026-08-14, 6496 rose 5.91%, moving from 22.85 to 24.20. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -37.73 and has improved across the 12-week window. Market Dynamics is 0.37 on the latest week. Next-week expectancy is undecided at 50.61% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
